Zenas BioPharma, Inc. Accrued Liabilities, Current
Zenas BioPharma, Inc. (ZBIO) had Accrued Liabilities, Current of $57.41 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2026-08-13
- 2026-06-30: Accrued Liabilities, Current $57.41M.
- 2026-03-31: Accrued Liabilities, Current $51.18M.
- 2025-12-31: Accrued Liabilities, Current $54.42M.
- 2025-09-30: Accrued Liabilities, Current $45.36M.
| Period end | Accrued Liabilities, Current |
|---|---|
| 2026-06-30 | $57.41M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $51.18M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $54.42M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $45.36M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $44.52M 10-Q · filed 2025-08-12 |
| 2025-03-31 | $28.21M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $39.37M 10-K · filed 2026-03-16 |
| 2024-09-30 | $28.53M 10-Q · filed 2024-11-12 |
| 2023-12-31 | $17.31M 10-K · filed 2025-03-11 |